NEWS
Medpage Today | Changed Warning on Statins; Novel Anticoagulant Shines; Porous Clots in Stroke

FDA is walking back the contraindication against statins for pregnant patients, but the agency maintains that most pregnant people should stop statin therapy. Rates of venous thromboembolism after elective total knee arthroplasty favored the novel factor XI inhibitor abelacimab over standard anticoagulant enoxaparin (Lovenox) in a phase II trial. (New England Journal of Medicine)

U.S. News | One-Dose Blood Thinner Could Slash Blood Clot Risk After Knee Replacement

TUESDAY, July 20, 2021 (HealthDay News) — Anyone who’s ever undergone knee replacement understands the real and troubling risk of post-op blood clots. Many patients are told take a daily blood thinner pill long after their procedure. But a new study finds that a one-time injection of an experimental blood thinner called abelacimab may greatly […]

MJBiz Daily | Online cannabis sales boom amid COVID-19 spurs delivery-service acquisitions

The explosive growth of e-commerce during the COVID-19 pandemic has propelled new interest in acquisitions involving direct-to-consumer cannabis delivery. Some marijuana companies have acquired delivery-only cannabis dispensaries, while others have spent more to acquire vertically integrated MJ firms with home-delivery operations included.